Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

PJP vs RSPH overlap: 21% of top holdings shared

Bottom line

How much do PJP and RSPH overlap?

21% of their top holdings overlap by weight. 6 securities appear in both funds' top 25, making up 25.4% of PJP's assets and 10.8% of RSPH's. They are substantially different portfolios, so owning both adds real diversification.

Updated Nov 22, 2026

Overlap at a glance

PJPRSPH
Weight overlap (top 25)21%
Shared holdings6
Weight in shared holdings25.4%10.8%
Total positions3363
Expense ratio0.58%0.4%
Holdings as ofJul 31, 2026Jul 31, 2026

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)

Holdings PJP and RSPH have in common

Holding% of PJP% of RSPHOverlap
Abbott Laboratories5.67%1.83%1.83%
AbbVie Inc.5.48%1.73%1.73%
Amgen Inc.5.33%1.77%1.77%
Regeneron Pharmaceuticals, Inc.3.14%1.96%1.96%
Bristol-Myers Squibb Co.2.94%1.82%1.82%
Viatris Inc.2.83%1.72%1.72%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in PJP

  1. Invesco Private Prime Fund — 7.93%
  2. Johnson & Johnson — 5.18%
  3. Merck & Co., Inc. — 5.06%
  4. Eli Lilly and Co. — 5.02%
  5. Corcept Therapeutics Inc. — 4.96%
  6. Gilead Sciences, Inc. — 4.53%
  7. Pfizer Inc. — 4.50%
  8. Amneal Pharmaceuticals, Inc. — 3.75%
  9. Invesco Private Government Fund — 3.73%
  10. Liquidia Corp. — 3.66%
  11. Travere Therapeutics, Inc. — 3.30%
  12. Ligand Pharmaceuticals Inc. — 3.20%
  13. Harmony Biosciences Holdings, Inc. — 3.06%
  14. Jazz Pharmaceuticals PLC — 2.79%
  15. Biogen Inc. — 2.75%

Only in RSPH

  1. Bio-Techne Corp. — 2.13%
  2. IQVIA Holdings Inc. — 2.00%
  3. Baxter International Inc. — 1.99%
  4. Mettler-Toledo International Inc. — 1.94%
  5. Charles River Laboratories International, Inc. — 1.93%
  6. Veeva Systems Inc. — 1.93%
  7. DaVita Inc. — 1.87%
  8. Moderna, Inc. — 1.85%
  9. Thermo Fisher Scientific Inc. — 1.84%
  10. Universal Health Services, Inc. — 1.80%
  11. Labcorp Holdings Inc. — 1.78%
  12. Quest Diagnostics Inc. — 1.77%
  13. Incyte Corp. — 1.76%
  14. Becton, Dickinson and Co. — 1.73%
  15. DexCom, Inc. — 1.73%

Asset mix

Asset typePJPRSPH
Stocks99.9%99.9%
Cash & short-term funds11.8%2.3%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)

Country mix

CountryPJPRSPH
US106.5%98.9%
IE5.2%3.4%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)

Check another pair

FAQ

How much do PJP and RSPH overlap?
About 21% by weight. 6 securities appear in both funds' top 25 holdings; they make up 25.4% of PJP's assets and 10.8% of RSPH's. They are substantially different portfolios, so owning both adds real diversification.
What stocks do PJP and RSPH have in common?
The largest shared holdings are Regeneron Pharmaceuticals, Inc., Abbott Laboratories, Bristol-Myers Squibb Co., Amgen Inc., AbbVie Inc..
Should I own both PJP and RSPH?
Their portfolios are mostly different, so owning both can add diversification. Check how each fits your overall allocation.
Which holds more stocks, PJP or RSPH?
RSPH is broader, with 63 positions versus 33 for PJP. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.